Nationwide Smoking Cessation Treatment Support Program - Turkey project

Health Policy

Volumn 119, Issue 1, 2015, Pages 50-56

  Çelik, Ismail ^a   Yüce, Deniz ^a   Hayran, Mutlu ^a   Erman, Mustafa ^a   Kiliçkap, Saadettin ^a   Buzgan, Turan ^b   Irmak, Hasan ^b   Tosun, Nihat ^b   Tuncer, Murat ^a   Akdağ, Recep ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bupropion; National support program; Smoking cessation; Varenicline

Indexed keywords

AMFEBUTAMONE; VARENICLINE; NICOTINE GUM;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING CESSATION TREATMENT SUPPORT PROGRAM; TOBACCO DEPENDENCE; TREATMENT DURATION; TURKEY (REPUBLIC); HEALTH CARE POLICY; PROCEDURES; PROGRAM EVALUATION; STATISTICS AND NUMERICAL DATA; TURKEY; UTILIZATION;

ADULT; BUPROPION; FEMALE; HEALTH POLICY; HUMANS; MALE; MIDDLE AGED; PROGRAM EVALUATION; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TURKEY; VARENICLINE;

EID: 84920688660     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2014.11.017     Document Type: Article

References (25)

1. WHO WHO report on the global tobacco epidemic 2011, World Health Organization, Geneva.
2. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nature Reviews Cancer 2009, 9:655-664.
3. Piné-Abata H., McNeill A., Raw M., Bitton A., Rigotti N., Murray R. A survey of tobacco dependence treatment guidelines in 121 countries. Addiction 2013, 108:1476-1484.
4. TCSB Küresel Yetişkin Tütün Araştirmasi Türkiye Raporu 2010, Sağlik Bakanliği Temel Sağlik Hizmetleri Genel Müdürlüğü, Ankara.
5. GATS-Global adult tobacco survey. Comparison Fact Sheet Turkey, 2008 and 2012. http://www.who.int/tobacco/surveillance/survey/gats/gats_turkey_2008v2012_comparison_fact_sheet.pdf.
6. Eisenberg M.J., Filion K.B., Yavin D., et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. Canadian Medical Association Journal 2008, 179:135-144.
7. Doolan D.M., Froelicher E.S. Smoking cessation interventions and older adults. Progress in Cardiovascular Nursing 2008, 23:119-127.
8. Doolan D.M., Stotts N.A., Benowitz N.L., Covinsky K.E., Froelicher E.S. The Women's Initiative for Nonsmoking (WINS) XI: age-related differences in smoking cessation responses among women with cardiovascular disease. American Journal Geriatric Cardiology 2008, 17:37-47.
9. Appel D.W., Aldrich T.K. Smoking cessation in the elderly. Clinics in Geriatric Medicine 2003, 19:77-100.
10. Marinho V., Laks J., Coutinho E.S., Blay S.L. Tobacco use among the elderly: a systematic review and meta-analysis. Cadernos de Saude Publica 2010, 26:2213-2233.
11. Tait R.J., Hulse G.K., Waterreus A., et al. Effectiveness of a smoking cessation intervention in older adults. Addiction 2007, 102:148-155.
12. Kupiainen H., Kinnula V.L., Lindqvist A., et al. Successful Smoking Cessation in COPD: Association with Comorbidities and Mortality. Pulmonary Medicine 2012, 72502:4. 10.1155/2012/725024.
13. Chelland Campbell S., Moffatt R.J., Stamford B.A. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:225-235.
14. Gorecka D., Bednarek M., Nowinski A., et al. Predictors of success in smoking cessation among participants of spirometric screening for COPD. Pneumonologia i Alergologia Polska 2001, 69:611-616.
15. Schiller J.S., Ni H. Cigarette smoking and smoking cessation among persons with chronic obstructive pulmonary disease. American Journal of Health Promotion 2006, 20:319-323.
16. Adams S.G., Pugh J.A., Kazis L.E., Lee S., Anzueto A. Characteristics associated with sustained abstinence from smoking among patients with COPD. American Journal of Medicine 2006, 119:441-447.
17. Kim D.K., Hersh C.P., Washko G.R., et al. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respiratory Research 2011, 12:9. 10.1186/1465-9921-12-9.
18. Williams J.M., Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors 2004, 29:1067-1083.
19. Hughes J.R., Kalman D. Do smokers with alcohol problems have more difficulty quitting. Drug and Alcohol Dependence 2006, 82:91-102.
20. Strassmann R., Bausch B., Spaar A., Kleijnen J., Braendli O., Puhan M.A. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. European Respiratory Journal 2009, 34:634-640.
21. Tashkin D., Kanner R., Bailey W., et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001, 357:1571-1575.
22. Ng T.P., Niti M., Fones C., Yap K.B., Tan W.C. Co-morbid association of depression and COPD: a population-based study. Respiratory Medicine 2009, 103:895-901.
23. Breslau N., Kilbey M.M., Andreski P. Vulnerability to psychopathology in nicotine-dependent smokers: an epidemiologic study of young adults. American Journal of Psychiatry 1993, 150:941-946.
24. Liberman J.N., Lichtenfeld M.J., Galaznik A., et al. Adherence to varenicline and associated smoking cessation in a community-based patient setting. Journal of Managed Care Pharmacy 2013, 19:125-131.
25. Nagelhout G.E., Willemsen M.C., van den Putte B., de Vries H., Willems R.A., Segaar D. Effectiveness of a national reimbursement policy and accompanying media attention on use of cessation treatment and on smoking cessation: a real-world study in the Netherlands. Tobacco Control 2014, pii:tobaccocontrol-2013-051430 [Epub ahead of print]. 10.1136/tobaccocontrol-2013-051430.